<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39302562</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1525-1497</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Sep</Month><Day>20</Day></PubDate></JournalIssue><Title>Journal of general internal medicine</Title><ISOAbbreviation>J Gen Intern Med</ISOAbbreviation></Journal><ArticleTitle>Risk of New-Onset Diabetes Before and During the COVID-19 Pandemic: A Real-World Cohort Study.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11606-024-09035-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Studies of new-onset diabetes as a post-acute sequela of SARS-CoV-2 infection are difficult to generalize to all socio-demographic subgroups.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To study the risk of new-onset diabetes after SARS-CoV-2 infection in a socio-demographically diverse sample.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective cohort study of electronic health record (EHR) data available from the OneFlorida&#x2009;+&#x2009;clinical research network within the National Patient-Centered Clinical Research Network (PCORnet).</AbstractText><AbstractText Label="SUBJECTS" NlmCategory="METHODS">Persons aged 18 or older were included as part of an Exposed cohort (positive SARS-CoV-2 test or COVID-19 diagnosis between 1 March 2020 and 29 January 2022; n&#x2009;=&#x2009;43,906), a contemporary unexposed cohort (negative SARS-CoV-2 test; n&#x2009;=&#x2009;162,683), or an age-sex matched historical control cohort (index visits between 2 Mar 2018 and 30 Jan 2020; n&#x2009;=&#x2009;40,957).</AbstractText><AbstractText Label="MAIN MEASURES" NlmCategory="METHODS">The primary outcome was new-onset type 2 diabetes&#x2009;&#x2265;&#x2009;30 days after index visit. Hazard ratios and cases per 1000 person-years of new-onset diabetes were studied using target trial approaches for observational data. Associations were reported by sex, race/ethnicity, age, and hospitalization status subgroups.</AbstractText><AbstractText Label="KEY RESULTS" NlmCategory="RESULTS">The sample was 62% female, 21.4% non-Hispanic Black, and 21.4% Hispanic; mean age was 51.8 (SD, 18.9) years. Relative to historical controls (cases, 28.2 [26.0-30.5]), the unexposed (HR, 1.28 [95% CI, 1.18-1.39]; excess cases, [5.1-10.3]), and exposed cohorts (HR, 1.64 [95% CI, 1.50-1.80]; excess cases, 17.3 [13.7-20.8]) had higher risk of new-onset T2DM. Relative to the unexposed cohort, the exposed cohort had a higher risk (HR, 1.28 [1.19-1.37]); excess cases, 9.5 [6.4-12.7]). Findings were similar across subgroups.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The pandemic period was associated with increased T2DM cases across all socio-demographic subgroups; the greatest risk was observed among individuals exposed to SARS-CoV-2.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s), under exclusive licence to Society of General Internal Medicine.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Varghese</LastName><ForeName>Jithin Sam</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Emory Global Diabetes Research Center of Woodruff Health Sciences Center and Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ali</LastName><ForeName>Mohammed K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Emory Global Diabetes Research Center of Woodruff Health Sciences Center and Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Family and Preventive Medicine, School of Medicine, Emory University, Atlanta, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donahoo</LastName><ForeName>William T</ForeName><Initials>WT</Initials><AffiliationInfo><Affiliation>Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chakkalakal</LastName><ForeName>Rosette J</ForeName><Initials>RJ</Initials><Identifier Source="ORCID">0000-0001-9318-1856</Identifier><AffiliationInfo><Affiliation>Emory Global Diabetes Research Center of Woodruff Health Sciences Center and Emory University, Atlanta, GA, 30322, USA. rchakka@emory.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Family and Preventive Medicine, School of Medicine, Emory University, Atlanta, USA. rchakka@emory.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, School of Medicine, Emory University, Atlanta, USA. rchakka@emory.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>3R01DK120814-05S1</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30DK111024</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Gen Intern Med</MedlineTA><NlmUniqueID>8605834</NlmUniqueID><ISSNLinking>0884-8734</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">diabetes risk</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post-acute sequelae of COVID-19</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>20</Day><Hour>13</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>20</Day><Hour>13</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>20</Day><Hour>11</Hour><Minute>19</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39302562</ArticleId><ArticleId IdType="doi">10.1007/s11606-024-09035-8</ArticleId><ArticleId IdType="pii">10.1007/s11606-024-09035-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. World Health Organization COVID-19 Emergency Dashboard [Internet]. 2023. Available from: https://covid19.who.int/region/amro/country/us . Accessed 22 Feb 2024</Citation></Reference><Reference><Citation>Cefalu WT. COVID-19 and Rising Incidence of Diabetes: Despite Evolving Data, an Enigma Still to Be Solved. Diabetes Care. 2023 May 1;46(5):913&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dci22-0067</ArticleId><ArticleId IdType="pubmed">37185693</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. The Lancet Diabetes &amp; Endocrinology. 2022;10(5):311&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00044-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T, Mei Q, Zhang Z, Walline JH, Liu Y, Zhu H, et al. Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis. BMC Med. 2022 Nov 15;20(1):444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02656-y</ArticleId><ArticleId IdType="pubmed">36380329</ArticleId><ArticleId IdType="pmc">9666960</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SH, Arora I, Hsia DS, Knowler WC, LeBlanc E, Mylonakis E, et al. New-Onset Diabetes After COVID-19. The Journal of Clinical Endocrinology &amp; Metabolism. 2023 Oct 18;108(11):e1164&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgad284</ArticleId></ArticleIdList></Reference><Reference><Citation>Izzo R, Pacella D, Trimarco V, Manzi MV, Lombardi A, Piccinocchi R, et al. Incidence of type 2 diabetes before and during the COVID-19 pandemic in Naples, Italy: a longitudinal cohort study. eClinicalMedicine. 2023 Dec;66:102345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.102345</ArticleId><ArticleId IdType="pubmed">38143804</ArticleId><ArticleId IdType="pmc">10746394</ArticleId></ArticleIdList></Reference><Reference><Citation>Mude W, Oguoma VM, Nyanhanda T, Mwanri L, Njue C. Racial disparities in COVID-19 pandemic cases, hospitalisations, and deaths: A systematic review and meta-analysis. J Glob Health. 2021 Jun 26;11:05015.</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.11.05015</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalsania AK, Fastiggi MJ, Kahlam A, Shah R, Patel K, Shiau S, et al. The Relationship Between Social Determinants of Health and Racial Disparities in COVID-19 Mortality. J Racial and Ethnic Health Disparities. 2022 Feb;9(1):288&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40615-020-00952-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Beckles GL, Chou CF. Disparities in the Prevalence of Diagnosed Diabetes &#x2014; United States, 1999&#x2013;2002 and 2011&#x2013;2014. MMWR Morb Mortal Wkly Rep. 2016 Nov 18;65(45):1265&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6545a4</ArticleId><ArticleId IdType="pubmed">27855140</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Khunti K, Nafilyan V, Maddox T, Humberstone B, Diamond I, et al. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. 2021 Mar 31;n693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n693</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez-Romieu AC, Carton TW, Saydah S, Azziz-Baumgartner E, Boehmer TK, Garret NY, et al. Prevalence of Select New Symptoms and Conditions Among Persons Aged Younger Than 20 Years and 20 Years or Older at 31 to 150 Days After Testing Positive or Negative for SARS-CoV-2. JAMA Netw Open. 2022 Feb 4;5(2):e2147053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.47053</ArticleId><ArticleId IdType="pubmed">35119459</ArticleId><ArticleId IdType="pmc">8817203</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugherty SE, Guo Y, Heath K, Dasmari&#xf1;as MC, Jubilo KG, Samranvedhya J, et al. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ. 2021 May 19;n1098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1098</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathmann W, Kuss O, Kostev K. Incidence of newly diagnosed diabetes after Covid-19. Diabetologia [Internet]. 2022 Mar 16 [cited 2022 Apr 22]; Available from: https://link.springer.com/ https://doi.org/10.1007/s00125-022-05670-0</Citation></Reference><Reference><Citation>Hogan WR, Shenkman EA, Robinson T, Carasquillo O, Robinson PS, Essner RZ, et al. The OneFlorida Data Trust: a centralized, translational research data infrastructure of statewide scope. Journal of the American Medical Informatics Association. 2022 Mar 15;29(4):686&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocab221</ArticleId><ArticleId IdType="pubmed">34664656</ArticleId></ArticleIdList></Reference><Reference><Citation>PCORnet. Common Data Model (CDM) Specification, Version 6.0 [Internet]. 2022. Available from: https://pcornet.org/wp-content/uploads/2022/01/PCORnet-Common-Data-Model-v60-2020_10_221.pdf</Citation></Reference><Reference><Citation>Wiese AD, Roumie CL, Buse JB, Guzman H, Bradford R, Zalimeni E, et al. Performance of a computable phenotype for identification of patients with diabetes within PCORnet: The Patient&#x2010;Centered Clinical Research Network. Pharmacoepidemiol Drug Saf. 2019 May;28(5):632&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.4718</ArticleId><ArticleId IdType="pubmed">30680840</ArticleId><ArticleId IdType="pmc">6615719</ArticleId></ArticleIdList></Reference><Reference><Citation>Benchimol EI, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I, et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement. PLoS Med. 2015 Oct 6;12(10):e1001885.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001885</ArticleId><ArticleId IdType="pubmed">26440803</ArticleId><ArticleId IdType="pmc">4595218</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Zang C, Xu Z, Zhang Y, Xu J, Bian J, et al. Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes. Nat Med. 2023 Jan;29(1):226&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02116-3</ArticleId><ArticleId IdType="pubmed">36456834</ArticleId></ArticleIdList></Reference><Reference><Citation>Rassen JA, Blin P, Kloss S, Neugebauer RS, Platt RW, Potteg&#xe5;rd A, et al. High&#x2010;dimensional propensity scores for empirical covariate selection in secondary database studies: Planning, implementation, and reporting. Pharmacoepidemiology and Drug. 2023 Feb;32(2):93&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.5566</ArticleId></ArticleIdList></Reference><Reference><Citation>Varghese JS, Guo Y, Ali MK, Donahoo WT, Chakkalakal RJ. Body mass index changes and their association with SARS-CoV-2 infection: a real-world analysis. International Journal of Obesity. 2024 September. https://www.nature.com/articles/s41366-024-01628-x</Citation></Reference><Reference><Citation>McCaffrey DF, Griffin BA, Almirall D, Slaughter ME, Ramchand R, Burgette LF. A tutorial on propensity score estimation for multiple treatments using generalized boosted models. Statist Med. 2013 Aug 30;32(19):3388&#x2013;414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.5753</ArticleId></ArticleIdList></Reference><Reference><Citation>Weuve J, Tchetgen Tchetgen EJ, Glymour MM, Beck TL, Aggarwal NT, Wilson RS, et al. Accounting for Bias Due to Selective Attrition: The Example of Smoking and Cognitive Decline. Epidemiology. 2012 Jan;23(1):119&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0b013e318230e861</ArticleId><ArticleId IdType="pubmed">21989136</ArticleId><ArticleId IdType="pmc">3237815</ArticleId></ArticleIdList></Reference><Reference><Citation>Robins JM, Hern&#xe1;n M&#xc1;, Brumback B. Marginal Structural Models and Causal Inference in Epidemiology: Epidemiology. 2000 Sep;11(5):550&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">10955408</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H. Causal Inference for Real-World Evidence: Propensity Score Methods and Case Study [Internet]. The ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop: US Food &amp; Drug Administration; 2020 Sep. Available from: https://ww2.amstat.org/meetings/biop/2020/onlineprogram/handouts/SC4-Handouts.pdf . Accessed 22 Feb 2024</Citation></Reference><Reference><Citation>Rubin DB, Thomas N. Combining Propensity Score Matching with Additional Adjustments for Prognostic Covariates. Journal of the American Statistical Association. 2000 Jun;95(450):573&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01621459.2000.10474233</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F, Thomas LE. Addressing Extreme Propensity Scores via the Overlap Weights. American Journal of Epidemiology [Internet]. 2018 Sep 5 [cited 2024 Mar 22]; Available from: https://academic.oup.com/aje/advance-article/doi/ https://doi.org/10.1093/aje/kwy201/5090958</Citation></Reference><Reference><Citation>Holman N, Barron E, Young B, Gregg EW, Khunti K, Valabhji J, et al. Comparative Incidence of Diabetes Following Hospital Admission for COVID-19 and Pneumonia: A Cohort Study. Diabetes Care. 2023 May 1;46(5):938&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc22-0670</ArticleId><ArticleId IdType="pubmed">36657086</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu CT, Lidsky PV, Xiao Y, Lee IT, Cheng R, Nakayama T, et al. SARS-CoV-2 infects human pancreatic &#x3b2; cells and elicits &#x3b2; cell impairment. Cell Metabolism. 2021 Aug;33(8):1565-1576.e5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2021.05.013</ArticleId><ArticleId IdType="pubmed">34081912</ArticleId><ArticleId IdType="pmc">8130512</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim S, Bae JH, Kwon HS, Nauck MA. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol. 2021 Jan;17(1):11&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-020-00435-4</ArticleId><ArticleId IdType="pubmed">33188364</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang X, Uhl S, Zhang T, Xue D, Li B, Vandana JJ, et al. SARS-CoV-2 infection induces beta cell transdifferentiation. Cell Metabolism. 2021 Aug;33(8):1577-1591.e7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2021.05.015</ArticleId><ArticleId IdType="pubmed">34081913</ArticleId><ArticleId IdType="pmc">8133495</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson CB, Farzan M, Chen B, Choe H. Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol. 2022 Jan;23(1):3&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-021-00418-x</ArticleId><ArticleId IdType="pubmed">34611326</ArticleId></ArticleIdList></Reference><Reference><Citation>Apicella M, Campopiano MC, Mantuano M, Mazoni L, Coppelli A, Del Prato S. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. The Lancet Diabetes &amp; Endocrinology. 2020 Sep;8(9):782&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(20)30238-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Landstra CP, de Koning EJP. COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course. Front Endocrinol. 2021 Jun 17;12:649525.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2021.649525</ArticleId></ArticleIdList></Reference><Reference><Citation>Gil S, Gualano B, Ara&#xfa;jo AL, J&#xfa;nior GNO, Damiano RF, Pinna F, et al. Association between Post-acute Sequelae of SARS-CoV-2 and Physical Inactivity: A Cohort Study of 614 COVID-19 survivors [Internet]. In Review; 2022 May [cited 2022 May 29]. Available from: https://www.researchsquare.com/article/rs-1638885/v1</Citation></Reference><Reference><Citation>Chen JL, Krupp GR, Lo JY. The COVID-19 Pandemic and Changes in Health Care Utilization Among Patients With Type 2 Diabetes. Diabetes Care. 2022 Apr 1;45(4):e74&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc21-2248</ArticleId><ArticleId IdType="pubmed">35085378</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control &amp; Prevention. National Diabetes Statistics Report [Internet]. 2023 [cited 2024 Feb 13]. Available from: https://www.cdc.gov/diabetes/data/statistics-report/index.html</Citation></Reference><Reference><Citation>Nichols GA, Schroeder EB, Karter AJ, Gregg EW, Desai J, Lawrence JM, et al. Trends in Diabetes Incidence Among 7 Million Insured Adults, 2006&#x2013;2011. American Journal of Epidemiology. 2015 Jan 1;181(1):32&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwu255</ArticleId><ArticleId IdType="pubmed">25515167</ArticleId></ArticleIdList></Reference><Reference><Citation>Madley-Dowd P, Hughes R, Tilling K, Heron J. The proportion of missing data should not be used to guide decisions on multiple imputation. Journal of Clinical Epidemiology. 2019 Jun;110:63&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2019.02.016</ArticleId><ArticleId IdType="pubmed">30878639</ArticleId><ArticleId IdType="pmc">6547017</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>